Deaminet 2026: Breakthroughs in Base Editing, Deaminase Biology, and Therapeutic Translation
Type
Blog Post
... al., 2025). In mice, AAV-delivered adaptamer-controlled FGF21 expression reversed obesity and metabolic...comorbidities, demonstrating tunable, re-dosable control of therapeutic transgenes via endogenous ADAR in...